name: Eylea Treat and Extend - NHS
version: '1.0'
created_date: '2025-01-21'
author: Clinical Team
description: NHS-specific treat-and-extend protocol with 8-week minimum interval after loading phase
protocol_type: treat_and_extend

# NHS constraint: minimum 8 weeks between injections after loading
min_interval_days: 56  # 8 weeks (NHS minimum)
max_interval_days: 112  # 16 weeks
extension_days: 14      # Extend by 2 weeks
shortening_days: 14     # Shorten by 2 weeks

# Disease transitions - same as standard T&E
disease_transitions:
  NAIVE:
    NAIVE: 0.0
    STABLE: 0.3
    ACTIVE: 0.6
    HIGHLY_ACTIVE: 0.1
  STABLE:
    NAIVE: 0.0
    STABLE: 0.85
    ACTIVE: 0.15
    HIGHLY_ACTIVE: 0.0
  ACTIVE:
    NAIVE: 0.0
    STABLE: 0.2
    ACTIVE: 0.7
    HIGHLY_ACTIVE: 0.1
  HIGHLY_ACTIVE:
    NAIVE: 0.0
    STABLE: 0.05
    ACTIVE: 0.15
    HIGHLY_ACTIVE: 0.8

# Treatment effects - same as standard
treatment_effect_on_transitions:
  NAIVE:
    multipliers: {}
  STABLE:
    multipliers:
      STABLE: 1.1
      ACTIVE: 0.9
  ACTIVE:
    multipliers:
      STABLE: 2.0
      ACTIVE: 0.8
      HIGHLY_ACTIVE: 0.5
  HIGHLY_ACTIVE:
    multipliers:
      STABLE: 2.0
      ACTIVE: 1.5
      HIGHLY_ACTIVE: 0.75

# Vision change model - same as standard
vision_change_model:
  naive_treated:
    mean: 2
    std: 2
  naive_untreated:
    mean: -2
    std: 2
  stable_treated:
    mean: 0.5
    std: 1
  stable_untreated:
    mean: -0.5
    std: 1
  active_treated:
    mean: -1
    std: 2
  active_untreated:
    mean: -3
    std: 2
  highly_active_treated:
    mean: -2
    std: 2
  highly_active_untreated:
    mean: -5
    std: 3

# Baseline vision distribution
baseline_vision_distribution:
  type: normal
  mean: 55
  std: 15
  min: 20
  max: 85

# Discontinuation rules
discontinuation_rules:
  poor_vision_threshold: 35
  poor_vision_probability: 0.1
  high_injection_count: 20
  high_injection_probability: 0.05
  long_treatment_months: 60
  long_treatment_probability: 0.02
  discontinuation_types:
  - planned
  - adverse
  - ineffective

# Loading phase configuration
loading_phase:
  enabled: true
  doses: 3
  interval_days: 28  # Monthly during loading

# NHS-specific notes
nhs_constraints:
  comment: "NHS protocols typically maintain 8-week minimum intervals after loading phase"
  rationale: "Resource constraints and clinic capacity"
  expected_impact: "May undertreat some patients who would benefit from 4-6 week intervals"